Jung Choi

2018

In 2018, Jung Choi earned a total compensation of $3.3M as Chief Business and Strategy Officer at Global Blood Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$185,000
Option Awards$1,326,469
Salary$392,063
Stock Awards$1,370,800
Other$5,000
Total$3,279,332

Choi received $1.4M in stock awards, accounting for 42% of the total pay in 2018.

Choi also received $185K in non-equity incentive plan, $1.3M in option awards, $392.1K in salary and $5K in other compensation.

Rankings

In 2018, Jung Choi's compensation ranked 3,505th out of 14,244 executives tracked by ExecPay. In other words, Choi earned more than 75.4% of executives.

ClassificationRankingPercentile
All
3,505
out of 14,244
75th
Division
Manufacturing
1,292
out of 5,759
78th
Major group
Chemicals And Allied Products
452
out of 2,122
79th
Industry group
Drugs
372
out of 1,811
80th
Industry
Pharmaceutical Preparations
285
out of 1,385
79th
Source: SEC filing on April 28, 2021.

Choi's colleagues

We found four more compensation records of executives who worked with Jung Choi at Global Blood Therapeutics in 2018.

2018

Ted Love

Global Blood Therapeutics

Chief Executive Officer

2018

David Johnson

Global Blood Therapeutics

Chief Commercial Officer

2018

Tricia Suvari

Global Blood Therapeutics

Chief Legal Officer

2018

Jeffrey Farrow

Global Blood Therapeutics

Chief Financial Officer

News

You may also like